| UniProt ID | HJURP_HUMAN | |
|---|---|---|
| UniProt AC | Q8NCD3 | |
| Protein Name | Holliday junction recognition protein | |
| Gene Name | HJURP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 748 | |
| Subcellular Localization | Nucleus, nucleolus. Chromosome, centromere. Localizes in centromeres during late telophase and early G1, when CENPA nucleosomes are assembled. Localizes to nucleolus during S phase, nucleolus site being often related to storage. | |
| Protein Description | Centromeric protein that plays a central role in the incorporation and maintenance of histone H3-like variant CENPA at centromeres. Acts as a specific chaperone for CENPA and is required for the incorporation of newly synthesized CENPA molecules into nucleosomes at replicated centromeres. Prevents CENPA-H4 tetramerization and prevents premature DNA binding by the CENPA-H4 tetramer. Directly binds Holliday junctions.. | |
| Protein Sequence | MLGTLRAMEGEDVEDDQLLQKLRASRRRFQRRMQRLIEKYNQPFEDTPVVQMATLTYETPQGLRIWGGRLIKERNEGEIQDSSMKPADRTDGSVQAAAWGPELPSHRTVLGADSKSGEVDATSDQEESVAWALAPAVPQSPLKNELRRKYLTQVDILLQGAEYFECAGNRAGRDVRVTPLPSLASPAVPAPGYCSRISRKSPGDPAKPASSPREWDPLHPSSTDMALVPRNDSLSLQETSSSSFLSSQPFEDDDICNVTISDLYAGMLHSMSRLLSTKPSSIISTKTFIMQNWNSRRRHRYKSRMNKTYCKGARRSQRSSKENFIPCSEPVKGTGALRDCKNVLDVSCRKTGLKLEKAFLEVNRPQIHKLDPSWKERKVTPSKYSSLIYFDSSATYNLDEENRFRTLKWLISPVKIVSRPTIRQGHGENRQREIEIRFDQLHREYCLSPRNQPRRMCLPDSWAMNMYRGGPASPGGLQGLETRRLSLPSSKAKAKSLSEAFENLGKRSLEAGRCLPKSDSSSSLPKTNPTHSATRPQQTSDLHVQGNSSGIFRKSVSPSKTLSVPDKEVPGHGRNRYDEIKEEFDKLHQKYCLKSPGQMTVPLCIGVSTDKASMEVRYQTEGFLGKLNPDPHFQGFQKLPSSPLGCRKSLLGSTAIEAPSSTCVARAITRDGTRDHQFPAKRPRLSEPQGSGRQGNSLGASDGVDNTVRPGDQGSSSQPNSEERGENTSYRMEEKSDFMLEKLETKSV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Sulfoxidation | MLGTLRAMEGEDVED CCCCCCCCCCCCCCC | 5.70 | 21406390 | |
| 21 | Ubiquitination | EDDQLLQKLRASRRR CCHHHHHHHHHHHHH | 39.65 | 21906983 | |
| 21 (in isoform 1) | Ubiquitination | - | 39.65 | 21890473 | |
| 21 (in isoform 2) | Ubiquitination | - | 39.65 | 21890473 | |
| 21 (in isoform 3) | Ubiquitination | - | 39.65 | 21890473 | |
| 25 | Phosphorylation | LLQKLRASRRRFQRR HHHHHHHHHHHHHHH | 21.64 | - | |
| 39 | Ubiquitination | RMQRLIEKYNQPFED HHHHHHHHHCCCCCC | 42.37 | 22817900 | |
| 39 (in isoform 1) | Ubiquitination | - | 42.37 | 21890473 | |
| 39 (in isoform 2) | Ubiquitination | - | 42.37 | 21890473 | |
| 39 (in isoform 3) | Ubiquitination | - | 42.37 | 21890473 | |
| 82 | Phosphorylation | NEGEIQDSSMKPADR CCCCCCCCCCCCCCC | 18.89 | - | |
| 83 | Phosphorylation | EGEIQDSSMKPADRT CCCCCCCCCCCCCCC | 38.83 | - | |
| 85 | Ubiquitination | EIQDSSMKPADRTDG CCCCCCCCCCCCCCC | 38.71 | 21906983 | |
| 85 (in isoform 1) | Ubiquitination | - | 38.71 | 21890473 | |
| 116 | Phosphorylation | VLGADSKSGEVDATS EECCCCCCCCCCCCC | 44.10 | 28102081 | |
| 122 | Phosphorylation | KSGEVDATSDQEESV CCCCCCCCCCCHHHH | 28.51 | 22617229 | |
| 122 | Ubiquitination | KSGEVDATSDQEESV CCCCCCCCCCCHHHH | 28.51 | 29967540 | |
| 123 | Phosphorylation | SGEVDATSDQEESVA CCCCCCCCCCHHHHH | 38.73 | 22617229 | |
| 128 | Phosphorylation | ATSDQEESVAWALAP CCCCCHHHHHHHHCC | 19.18 | 22617229 | |
| 140 | Phosphorylation | LAPAVPQSPLKNELR HCCCCCCCCCCHHHH | 26.57 | 26055452 | |
| 153 | Ubiquitination | LRRKYLTQVDILLQG HHHHHHHHHHHHHHC | 28.43 | 29967540 | |
| 163 | Phosphorylation | ILLQGAEYFECAGNR HHHHCHHHEECCCCC | 12.25 | - | |
| 166 | Ubiquitination | QGAEYFECAGNRAGR HCHHHEECCCCCCCC | 4.16 | 21890473 | |
| 178 | Phosphorylation | AGRDVRVTPLPSLAS CCCCCEECCCCCCCC | 14.45 | 25159151 | |
| 182 | Phosphorylation | VRVTPLPSLASPAVP CEECCCCCCCCCCCC | 44.22 | 25159151 | |
| 185 | Phosphorylation | TPLPSLASPAVPAPG CCCCCCCCCCCCCCC | 20.77 | 25159151 | |
| 193 | Phosphorylation | PAVPAPGYCSRISRK CCCCCCCCCCCCCCC | 6.03 | 29396449 | |
| 193 | Ubiquitination | PAVPAPGYCSRISRK CCCCCCCCCCCCCCC | 6.03 | 27667366 | |
| 193 (in isoform 3) | Ubiquitination | - | 6.03 | 21890473 | |
| 195 | Phosphorylation | VPAPGYCSRISRKSP CCCCCCCCCCCCCCC | 24.94 | 26552605 | |
| 198 | Phosphorylation | PGYCSRISRKSPGDP CCCCCCCCCCCCCCC | 32.33 | 24719451 | |
| 201 | Phosphorylation | CSRISRKSPGDPAKP CCCCCCCCCCCCCCC | 32.76 | 30266825 | |
| 207 | Ubiquitination | KSPGDPAKPASSPRE CCCCCCCCCCCCCCC | 46.64 | 29967540 | |
| 210 | Phosphorylation | GDPAKPASSPREWDP CCCCCCCCCCCCCCC | 49.77 | 30266825 | |
| 211 | Phosphorylation | DPAKPASSPREWDPL CCCCCCCCCCCCCCC | 30.04 | 30266825 | |
| 221 | Phosphorylation | EWDPLHPSSTDMALV CCCCCCCCCCCEEEE | 34.81 | 22199227 | |
| 222 | Phosphorylation | WDPLHPSSTDMALVP CCCCCCCCCCEEEEE | 32.64 | 22199227 | |
| 223 | Phosphorylation | DPLHPSSTDMALVPR CCCCCCCCCEEEEEC | 33.85 | 22199227 | |
| 224 | Ubiquitination | PLHPSSTDMALVPRN CCCCCCCCEEEEECC | 23.47 | 27667366 | |
| 224 (in isoform 2) | Ubiquitination | - | 23.47 | 21890473 | |
| 236 | Ubiquitination | PRNDSLSLQETSSSS ECCCCCCCEECCCCC | 6.91 | 33845483 | |
| 247 | Ubiquitination | SSSSFLSSQPFEDDD CCCCCCCCCCCCCCC | 43.98 | 33845483 | |
| 256 | Ubiquitination | PFEDDDICNVTISDL CCCCCCCCCEEHHHH | 4.27 | 33845483 | |
| 267 | Ubiquitination | ISDLYAGMLHSMSRL HHHHHHHHHHHHHHH | 2.01 | 33845483 | |
| 269 | Ubiquitination | DLYAGMLHSMSRLLS HHHHHHHHHHHHHHC | 16.74 | 29967540 | |
| 272 | Ubiquitination | AGMLHSMSRLLSTKP HHHHHHHHHHHCCCC | 23.85 | 29967540 | |
| 276 | Phosphorylation | HSMSRLLSTKPSSII HHHHHHHCCCCHHCE | 38.69 | 24719451 | |
| 278 | Ubiquitination | MSRLLSTKPSSIIST HHHHHCCCCHHCEEE | 39.26 | 27667366 | |
| 278 (in isoform 1) | Ubiquitination | - | 39.26 | 21890473 | |
| 280 | Phosphorylation | RLLSTKPSSIISTKT HHHCCCCHHCEEEHH | 35.41 | 27732954 | |
| 281 | Phosphorylation | LLSTKPSSIISTKTF HHCCCCHHCEEEHHH | 32.25 | 27732954 | |
| 284 | Phosphorylation | TKPSSIISTKTFIMQ CCCHHCEEEHHHHHH | 23.37 | 27732954 | |
| 284 | Ubiquitination | TKPSSIISTKTFIMQ CCCHHCEEEHHHHHH | 23.37 | 29967540 | |
| 285 | Phosphorylation | KPSSIISTKTFIMQN CCHHCEEEHHHHHHC | 24.56 | 27732954 | |
| 286 | Ubiquitination | PSSIISTKTFIMQNW CHHCEEEHHHHHHCC | 34.35 | - | |
| 287 | Ubiquitination | SSIISTKTFIMQNWN HHCEEEHHHHHHCCH | 20.62 | 33845483 | |
| 290 | Ubiquitination | ISTKTFIMQNWNSRR EEEHHHHHHCCHHHH | 1.89 | 33845483 | |
| 296 | Ubiquitination | IMQNWNSRRRHRYKS HHHCCHHHHHHHHHH | 36.12 | 21890473 | |
| 300 | Ubiquitination | WNSRRRHRYKSRMNK CHHHHHHHHHHHCCH | 38.47 | 29967540 | |
| 303 | Phosphorylation | RRRHRYKSRMNKTYC HHHHHHHHHCCHHHH | 28.03 | 18452278 | |
| 303 | Ubiquitination | RRRHRYKSRMNKTYC HHHHHHHHHCCHHHH | 28.03 | 29967540 | |
| 315 | Ubiquitination | TYCKGARRSQRSSKE HHHHHHHHHHCCCCC | 36.29 | 29967540 | |
| 321 | Ubiquitination | RRSQRSSKENFIPCS HHHHCCCCCCCCCCC | 58.90 | 33845483 | |
| 323 | Ubiquitination | SQRSSKENFIPCSEP HHCCCCCCCCCCCCC | 43.83 | 21890473 | |
| 323 (in isoform 3) | Ubiquitination | - | 43.83 | 21890473 | |
| 328 | Phosphorylation | KENFIPCSEPVKGTG CCCCCCCCCCCCCCC | 39.31 | 21815630 | |
| 332 | Ubiquitination | IPCSEPVKGTGALRD CCCCCCCCCCCHHHH | 62.56 | 33845483 | |
| 341 | Acetylation | TGALRDCKNVLDVSC CCHHHHCCCCCCHHH | 55.14 | 25953088 | |
| 341 | Ubiquitination | TGALRDCKNVLDVSC CCHHHHCCCCCCHHH | 55.14 | 33845483 | |
| 347 | Phosphorylation | CKNVLDVSCRKTGLK CCCCCCHHHHHHCCC | 14.10 | 21815630 | |
| 354 | Sumoylation | SCRKTGLKLEKAFLE HHHHHCCCHHHHHHH | 56.81 | 28112733 | |
| 354 | Ubiquitination | SCRKTGLKLEKAFLE HHHHHCCCHHHHHHH | 56.81 | 23000965 | |
| 354 (in isoform 2) | Ubiquitination | - | 56.81 | 21890473 | |
| 357 | Ubiquitination | KTGLKLEKAFLEVNR HHCCCHHHHHHHCCC | 55.67 | 29967540 | |
| 369 | Ubiquitination | VNRPQIHKLDPSWKE CCCHHHHCCCCCHHH | 57.10 | 29967540 | |
| 375 | Ubiquitination | HKLDPSWKERKVTPS HCCCCCHHHCCCCHH | 52.56 | 33845483 | |
| 380 | O-linked_Glycosylation | SWKERKVTPSKYSSL CHHHCCCCHHHCCEE | 25.53 | 30379171 | |
| 380 | Phosphorylation | SWKERKVTPSKYSSL CHHHCCCCHHHCCEE | 25.53 | 24719451 | |
| 382 | Phosphorylation | KERKVTPSKYSSLIY HHCCCCHHHCCEEEE | 34.56 | - | |
| 401 | Phosphorylation | ATYNLDEENRFRTLK CCCCCCCHHCHHHHH | 54.06 | 32142685 | |
| 408 | Sumoylation | ENRFRTLKWLISPVK HHCHHHHHHHHCCCE | 39.06 | - | |
| 408 | Sumoylation | ENRFRTLKWLISPVK HHCHHHHHHHHCCCE | 39.06 | - | |
| 408 | Ubiquitination | ENRFRTLKWLISPVK HHCHHHHHHHHCCCE | 39.06 | 23000965 | |
| 408 (in isoform 1) | Ubiquitination | - | 39.06 | 21890473 | |
| 410 | Ubiquitination | RFRTLKWLISPVKIV CHHHHHHHHCCCEEE | 2.38 | 29967540 | |
| 412 | Phosphorylation | RTLKWLISPVKIVSR HHHHHHHCCCEEECC | 22.82 | 19664994 | |
| 415 | Ubiquitination | KWLISPVKIVSRPTI HHHHCCCEEECCCCC | 40.55 | - | |
| 418 | Phosphorylation | ISPVKIVSRPTIRQG HCCCEEECCCCCCCC | 35.70 | 22468782 | |
| 421 | Phosphorylation | VKIVSRPTIRQGHGE CEEECCCCCCCCCCC | 27.90 | 23312004 | |
| 421 | Ubiquitination | VKIVSRPTIRQGHGE CEEECCCCCCCCCCC | 27.90 | 29967540 | |
| 432 | Phosphorylation | GHGENRQREIEIRFD CCCCCCCEEEEEEHH | 43.56 | 32142685 | |
| 432 | Ubiquitination | GHGENRQREIEIRFD CCCCCCCEEEEEEHH | 43.56 | 29967540 | |
| 441 | Ubiquitination | IEIRFDQLHREYCLS EEEEHHHHHHHHHCC | 4.41 | 29967540 | |
| 445 | Phosphorylation | FDQLHREYCLSPRNQ HHHHHHHHHCCCCCC | 9.92 | 29396449 | |
| 448 | Phosphorylation | LHREYCLSPRNQPRR HHHHHHCCCCCCCCC | 20.46 | 19664994 | |
| 452 | Ubiquitination | YCLSPRNQPRRMCLP HHCCCCCCCCCCCCC | 33.87 | 29967540 | |
| 461 | Phosphorylation | RRMCLPDSWAMNMYR CCCCCCCHHHHHCCC | 18.13 | 24043423 | |
| 463 | Ubiquitination | MCLPDSWAMNMYRGG CCCCCHHHHHCCCCC | 5.39 | 29967540 | |
| 467 | Phosphorylation | DSWAMNMYRGGPASP CHHHHHCCCCCCCCC | 10.91 | 24043423 | |
| 472 | Phosphorylation | NMYRGGPASPGGLQG HCCCCCCCCCCCCCC | 31.47 | 32645325 | |
| 472 | Ubiquitination | NMYRGGPASPGGLQG HCCCCCCCCCCCCCC | 31.47 | 29967540 | |
| 473 | Phosphorylation | MYRGGPASPGGLQGL CCCCCCCCCCCCCCH | 27.49 | 19664994 | |
| 482 | Phosphorylation | GGLQGLETRRLSLPS CCCCCHHHCCCCCCC | 26.57 | 23927012 | |
| 482 | Ubiquitination | GGLQGLETRRLSLPS CCCCCHHHCCCCCCC | 26.57 | 29967540 | |
| 486 | Phosphorylation | GLETRRLSLPSSKAK CHHHCCCCCCCHHHH | 36.10 | 23401153 | |
| 489 | Phosphorylation | TRRLSLPSSKAKAKS HCCCCCCCHHHHHHH | 50.17 | 22617229 | |
| 490 | Phosphorylation | RRLSLPSSKAKAKSL CCCCCCCHHHHHHHH | 34.39 | 25159151 | |
| 493 | Ubiquitination | SLPSSKAKAKSLSEA CCCCHHHHHHHHHHH | 61.15 | - | |
| 495 | Sumoylation | PSSKAKAKSLSEAFE CCHHHHHHHHHHHHH | 51.74 | - | |
| 495 | Methylation | PSSKAKAKSLSEAFE CCHHHHHHHHHHHHH | 51.74 | 82974403 | |
| 495 | Sumoylation | PSSKAKAKSLSEAFE CCHHHHHHHHHHHHH | 51.74 | - | |
| 495 | Ubiquitination | PSSKAKAKSLSEAFE CCHHHHHHHHHHHHH | 51.74 | 29967540 | |
| 496 | Phosphorylation | SSKAKAKSLSEAFEN CHHHHHHHHHHHHHH | 41.82 | 25159151 | |
| 496 | Ubiquitination | SSKAKAKSLSEAFEN CHHHHHHHHHHHHHH | 41.82 | 29967540 | |
| 498 | Phosphorylation | KAKAKSLSEAFENLG HHHHHHHHHHHHHHH | 33.69 | 27050516 | |
| 501 | Ubiquitination | AKSLSEAFENLGKRS HHHHHHHHHHHHHHH | 5.85 | 29967540 | |
| 503 | Phosphorylation | SLSEAFENLGKRSLE HHHHHHHHHHHHHHH | 47.87 | 32645325 | |
| 505 | Ubiquitination | SEAFENLGKRSLEAG HHHHHHHHHHHHHHC | 34.61 | 29967540 | |
| 506 | Acetylation | EAFENLGKRSLEAGR HHHHHHHHHHHHHCC | 41.81 | 25953088 | |
| 506 | Methylation | EAFENLGKRSLEAGR HHHHHHHHHHHHHCC | 41.81 | 115970695 | |
| 506 | Ubiquitination | EAFENLGKRSLEAGR HHHHHHHHHHHHHCC | 41.81 | 29967540 | |
| 508 | Phosphorylation | FENLGKRSLEAGRCL HHHHHHHHHHHCCCC | 33.76 | - | |
| 509 | Ubiquitination | ENLGKRSLEAGRCLP HHHHHHHHHHCCCCC | 6.41 | 29967540 | |
| 513 | Ubiquitination | KRSLEAGRCLPKSDS HHHHHHCCCCCCCCC | 26.33 | 29967540 | |
| 517 | Sumoylation | EAGRCLPKSDSSSSL HHCCCCCCCCCCCCC | 54.68 | - | |
| 517 | Sumoylation | EAGRCLPKSDSSSSL HHCCCCCCCCCCCCC | 54.68 | - | |
| 517 | Ubiquitination | EAGRCLPKSDSSSSL HHCCCCCCCCCCCCC | 54.68 | 29967540 | |
| 518 | Phosphorylation | AGRCLPKSDSSSSLP HCCCCCCCCCCCCCC | 40.56 | 26852163 | |
| 520 | Phosphorylation | RCLPKSDSSSSLPKT CCCCCCCCCCCCCCC | 38.93 | 21815630 | |
| 521 | Phosphorylation | CLPKSDSSSSLPKTN CCCCCCCCCCCCCCC | 29.01 | 29396449 | |
| 522 | Phosphorylation | LPKSDSSSSLPKTNP CCCCCCCCCCCCCCC | 39.59 | 29396449 | |
| 523 | Phosphorylation | PKSDSSSSLPKTNPT CCCCCCCCCCCCCCC | 51.11 | 29396449 | |
| 526 | Ubiquitination | DSSSSLPKTNPTHSA CCCCCCCCCCCCCCC | 67.25 | 29967540 | |
| 527 | Ubiquitination | SSSSLPKTNPTHSAT CCCCCCCCCCCCCCC | 44.48 | 29967540 | |
| 532 | Phosphorylation | PKTNPTHSATRPQQT CCCCCCCCCCCCCCC | 33.54 | 25627689 | |
| 532 | Ubiquitination | PKTNPTHSATRPQQT CCCCCCCCCCCCCCC | 33.54 | 29967540 | |
| 534 | Phosphorylation | TNPTHSATRPQQTSD CCCCCCCCCCCCCCE | 45.99 | 28555341 | |
| 536 | Ubiquitination | PTHSATRPQQTSDLH CCCCCCCCCCCCEEE | 26.69 | 29967540 | |
| 539 | Phosphorylation | SATRPQQTSDLHVQG CCCCCCCCCEEEECC | 20.97 | 28555341 | |
| 540 | Ubiquitination | ATRPQQTSDLHVQGN CCCCCCCCEEEECCC | 33.56 | 29967540 | |
| 541 | Ubiquitination | TRPQQTSDLHVQGNS CCCCCCCEEEECCCC | 44.15 | 29967540 | |
| 549 | Phosphorylation | LHVQGNSSGIFRKSV EEECCCCCCCEECCC | 39.65 | 28555341 | |
| 553 | Ubiquitination | GNSSGIFRKSVSPSK CCCCCCEECCCCCCC | 28.55 | 29967540 | |
| 555 | Phosphorylation | SSGIFRKSVSPSKTL CCCCEECCCCCCCCC | 24.46 | 23927012 | |
| 557 | Phosphorylation | GIFRKSVSPSKTLSV CCEECCCCCCCCCCC | 30.46 | 23401153 | |
| 559 | Phosphorylation | FRKSVSPSKTLSVPD EECCCCCCCCCCCCC | 30.66 | 28464451 | |
| 561 | Phosphorylation | KSVSPSKTLSVPDKE CCCCCCCCCCCCCCC | 28.71 | 28464451 | |
| 563 | Phosphorylation | VSPSKTLSVPDKEVP CCCCCCCCCCCCCCC | 36.51 | 28464451 | |
| 563 | Ubiquitination | VSPSKTLSVPDKEVP CCCCCCCCCCCCCCC | 36.51 | 29967540 | |
| 567 | Acetylation | KTLSVPDKEVPGHGR CCCCCCCCCCCCCCC | 55.32 | 25953088 | |
| 567 | Ubiquitination | KTLSVPDKEVPGHGR CCCCCCCCCCCCCCC | 55.32 | 29967540 | |
| 572 | Ubiquitination | PDKEVPGHGRNRYDE CCCCCCCCCCCCHHH | 26.43 | 29967540 | |
| 581 | Sumoylation | RNRYDEIKEEFDKLH CCCHHHHHHHHHHHH | 49.49 | - | |
| 581 | Sumoylation | RNRYDEIKEEFDKLH CCCHHHHHHHHHHHH | 49.49 | 28112733 | |
| 581 | Ubiquitination | RNRYDEIKEEFDKLH CCCHHHHHHHHHHHH | 49.49 | 29967540 | |
| 584 | Ubiquitination | YDEIKEEFDKLHQKY HHHHHHHHHHHHHHH | 12.00 | 29967540 | |
| 586 | Sumoylation | EIKEEFDKLHQKYCL HHHHHHHHHHHHHCC | 53.87 | 28112733 | |
| 586 | Ubiquitination | EIKEEFDKLHQKYCL HHHHHHHHHHHHHCC | 53.87 | 29967540 | |
| 590 | Ubiquitination | EFDKLHQKYCLKSPG HHHHHHHHHCCCCCC | 27.47 | 29967540 | |
| 591 | Phosphorylation | FDKLHQKYCLKSPGQ HHHHHHHHCCCCCCC | 9.10 | 29083192 | |
| 594 | Ubiquitination | LHQKYCLKSPGQMTV HHHHHCCCCCCCCEE | 51.55 | 29967540 | |
| 595 | Phosphorylation | HQKYCLKSPGQMTVP HHHHCCCCCCCCEEE | 22.70 | 29255136 | |
| 596 | Ubiquitination | QKYCLKSPGQMTVPL HHHCCCCCCCCEEEE | 35.13 | 29967540 | |
| 600 | Phosphorylation | LKSPGQMTVPLCIGV CCCCCCCEEEEEEEE | 15.87 | 29255136 | |
| 608 | Phosphorylation | VPLCIGVSTDKASME EEEEEEEECCCCCCE | 26.19 | 22199227 | |
| 609 | Phosphorylation | PLCIGVSTDKASMEV EEEEEEECCCCCCEE | 38.83 | 22199227 | |
| 611 | Ubiquitination | CIGVSTDKASMEVRY EEEEECCCCCCEEEE | 42.31 | - | |
| 626 | Acetylation | QTEGFLGKLNPDPHF CCCCCHHCCCCCCCC | 47.43 | 25953088 | |
| 626 | Ubiquitination | QTEGFLGKLNPDPHF CCCCCHHCCCCCCCC | 47.43 | 29967540 | |
| 627 | Ubiquitination | TEGFLGKLNPDPHFQ CCCCHHCCCCCCCCC | 12.19 | 29967540 | |
| 638 | Ubiquitination | PHFQGFQKLPSSPLG CCCCCCCCCCCCCCC | 61.17 | 29967540 | |
| 641 | Phosphorylation | QGFQKLPSSPLGCRK CCCCCCCCCCCCCCH | 55.83 | 30266825 | |
| 642 | Phosphorylation | GFQKLPSSPLGCRKS CCCCCCCCCCCCCHH | 23.39 | 29255136 | |
| 648 | Sumoylation | SSPLGCRKSLLGSTA CCCCCCCHHHHCCCC | 49.92 | - | |
| 648 | Sumoylation | SSPLGCRKSLLGSTA CCCCCCCHHHHCCCC | 49.92 | - | |
| 648 | Ubiquitination | SSPLGCRKSLLGSTA CCCCCCCHHHHCCCC | 49.92 | 29967540 | |
| 649 | Phosphorylation | SPLGCRKSLLGSTAI CCCCCCHHHHCCCCE | 14.96 | 22199227 | |
| 653 | Phosphorylation | CRKSLLGSTAIEAPS CCHHHHCCCCEECCC | 18.03 | 30576142 | |
| 654 | Phosphorylation | RKSLLGSTAIEAPSS CHHHHCCCCEECCCC | 29.83 | 30576142 | |
| 660 | Phosphorylation | STAIEAPSSTCVARA CCCEECCCCCEEEEE | 45.38 | 29396449 | |
| 661 | Phosphorylation | TAIEAPSSTCVARAI CCEECCCCCEEEEEH | 25.43 | 28555341 | |
| 662 | Phosphorylation | AIEAPSSTCVARAIT CEECCCCCEEEEEHH | 18.48 | 29396449 | |
| 681 | Ubiquitination | RDHQFPAKRPRLSEP CCCCCCCCCCCCCCC | 64.27 | 29967540 | |
| 686 | Phosphorylation | PAKRPRLSEPQGSGR CCCCCCCCCCCCCCC | 48.81 | 21815630 | |
| 691 | Phosphorylation | RLSEPQGSGRQGNSL CCCCCCCCCCCCCCC | 26.09 | 23532336 | |
| 707 | Phosphorylation | ASDGVDNTVRPGDQG CCCCCCCCCCCCCCC | 17.27 | 28985074 | |
| 735 | Sumoylation | TSYRMEEKSDFMLEK CCCCHHHHCHHHHHH | 41.86 | - | |
| 735 | Sumoylation | TSYRMEEKSDFMLEK CCCCHHHHCHHHHHH | 41.86 | - | |
| 736 | Phosphorylation | SYRMEEKSDFMLEKL CCCHHHHCHHHHHHH | 39.08 | - | |
| 739 | Sulfoxidation | MEEKSDFMLEKLETK HHHHCHHHHHHHHCC | 5.92 | 21406390 | |
| 742 | Sumoylation | KSDFMLEKLETKSV- HCHHHHHHHHCCCC- | 47.89 | - | |
| 742 | Sumoylation | KSDFMLEKLETKSV- HCHHHHHHHHCCCC- | 47.89 | - | |
| 745 | Phosphorylation | FMLEKLETKSV---- HHHHHHHCCCC---- | 38.77 | 23312004 | |
| 747 | Phosphorylation | LEKLETKSV------ HHHHHCCCC------ | 40.24 | 21712546 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 412 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 448 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 473 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 486 | S | Phosphorylation | Kinase | AKT1 | P31749 | Uniprot |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HJURP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HJURP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MIC60_HUMAN | IMMT | physical | 16169070 | |
| CENPA_YEAST | CSE4 | genetic | 21980305 | |
| CENPA_HUMAN | CENPA | genetic | 21980305 | |
| CENPA_HUMAN | CENPA | physical | 19410545 | |
| CENPA_HUMAN | CENPA | physical | 19410544 | |
| CENPA_HUMAN | CENPA | physical | 21478274 | |
| CENPA_HUMAN | CENPA | physical | 20080577 | |
| RUVB1_HUMAN | RUVBL1 | physical | 20080577 | |
| RUVB2_HUMAN | RUVBL2 | physical | 20080577 | |
| RBBP7_HUMAN | RBBP7 | physical | 20080577 | |
| RBBP4_HUMAN | RBBP4 | physical | 20080577 | |
| NPM_HUMAN | NPM1 | physical | 20080577 | |
| CENPA_XENLA | cenpa | physical | 21321101 | |
| CENPA_HUMAN | CENPA | physical | 22406139 | |
| TBA3C_HUMAN | TUBA3C | physical | 26186194 | |
| MS18A_HUMAN | MIS18A | physical | 26186194 | |
| DUS1L_HUMAN | DUS1L | physical | 26186194 | |
| CENPA_HUMAN | CENPA | physical | 25727006 | |
| DUS1L_HUMAN | DUS1L | physical | 28514442 | |
| TBA3C_HUMAN | TUBA3C | physical | 28514442 | |
| MS18A_HUMAN | MIS18A | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-185; SER-473 ANDSER-642, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-122; SER-140; SER-412;SER-448; SER-473 AND SER-642, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473; SER-486 ANDSER-642, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-185 AND SER-642, ANDMASS SPECTROMETRY. | |
| "Identification of FAKTS as a novel 14-3-3-associated nuclearprotein."; Luhn P., Wang H., Marcus A.I., Fu H.; Proteins 67:479-489(2007). Cited for: INTERACTION WITH 14-3-3 PROTEINS, SUBCELLULAR LOCATION, TISSUESPECIFICITY, PHOSPHORYLATION AT SER-486, AND MUTAGENESIS OF SER-486. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-473, ANDMASS SPECTROMETRY. | |